NCT01208116

Brief Summary

The purpose of this study is to determine whether non-invasive atherosclerotic measurements (baPWV, IMT, FMD, CACS, ABI) are valuable predictors for cardiovascular events in elderly. At inception, routine physical examination and non-invasive atherosclerotic measurements will conducted on all participants. Then they will be followed prospectively for at least 2 years. All cardiovascular and other health events will be recorded.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,290

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 22, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 23, 2010

Completed
Last Updated

September 23, 2010

Status Verified

September 1, 2010

First QC Date

September 22, 2010

Last Update Submit

September 22, 2010

Conditions

AtherosclerosisCardiovascular Disease

Keywords

AtherosclerosisPrognosisFlow-mediated dilatationBrachial-ankle pulse wave velocityCarotid Intimal-Medial Thicknesscoronary artery calcification scoreAnkle-brachial index

Study Arms (1)

Subgroups

According to the demographic features, subjects may be divided into some subgroups.

Other: Cardiovascular events

Interventions

Cardiovascular eventsOTHER

* Coronary intervention * Infarction * Congestive heart failure * Stroke * Cardiac death

Subgroups

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects with an age\>=60 years, who are designated for healthcare in Tianjin Medical University General Hospital will be enrolled in the study and there is no restriction on gender. Medical histroy are recorded precisely. The protocol was approved by our Institutional Ethics Committee and all subjects give informed consent before participating.

You may qualify if:

  • Chinese, age\>=60, no gender restriction.
  • To be able to apply the measurement mentioned above.
  • Medical history are maintained precisely.
  • Tianjin Medical University General Hospital is the participants' designated hospital by national health authority.

You may not qualify if:

  • Systemic inflammation.
  • Malignant tumor
  • Chronic lung disease
  • Liver disease
  • Aortic aneurysm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Geriatric Department, Tianjin Medical University General Hospital

Tianjin, Tianjin Municipality, 300052, China

RECRUITING

MeSH Terms

Conditions

AtherosclerosisCardiovascular Diseases

Condition Hierarchy (Ancestors)

ArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Ning Sun, M.D.

    Tianjin Medical University General Hospital

    STUDY DIRECTOR

Central Study Contacts

Ning Sun, M.D.

CONTACT

+86 13820220028ss9981@sina.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 22, 2010

First Posted

September 23, 2010

Study Start

April 1, 2010

Last Updated

September 23, 2010

Record last verified: 2010-09

Locations

CN(1)